CD8A and cancer: Meanwhile, focusing on UPR promoting cancer immune escape, we discussed the mechanisms by which UPR inhibits anticancer immunity and reshapes the immunosuppressive TME through cancer cells, anticancer immune cells (NK cells, DCs, and CD8+ T cells), and immunosuppressive cells (M2 macrophages and myeloid‐derived suppressor cells [MDSCs]).